HSBC Holdings
CTIC

HSBC Holdings’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

HSBC Holdings’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,283
Closed -$31K – 1886
2014
Q3 		$31K Buy
1,283
+173
+16% +$4.5K ﹤0.01% 1716
2014
Q2 		$31K Buy
+1,110
New +$33.4K ﹤0.01% 1738

Other funds holding CTIC

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

HSBC Holdings's CTIC Position: Q4 2014 in Review

HSBC Holdings sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q4 2014, closing a stake of 1,283 shares — an estimated $31K sold.

HSBC Holdings first reported a position in CTIC in Q2 2014 and held it in 2 quarters. The position peaked at $31K in Q3 2014. 90 funds tracked by Wall St. Rank hold CTIC as of Q4 2014.

  • HSBC Holdings reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q4 2014 after selling out during the quarter.
  • HSBC Holdings sold 1,283 CTI BioPharma Corp. (DE) Common Stock shares in Q4 2014, an estimated $31K.
  • HSBC Holdings first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2014 and held it in 2 quarters.
  • HSBC Holdings's CTI BioPharma Corp. (DE) Common Stock position peaked at $31K in Q3 2014.
  • 90 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q4 2014.

Based on HSBC Holdings's 13F filing for Q4 2014, filed 13 Feb 2015.